Progressive multifocal leukoencephalopathy in Zambia is caused by JC virus with prototype regulatory region
Tóm tắt
There are only few documented cases of progressive multifocal leukoencephalopathy (PML) in Africa. Whether this is caused by a lack of JC virus (JCV) spread or alteration in the JCV genome is unknown. We characterized the clinical presentation, laboratory findings, and JCV regulatory region (RR) pattern of the first documented PML cases in Zambia as well as JCV seroprevalence among HIV+ and HIV− Zambians. We identified PML patients with positive JCV DNA PCR in their cerebrospinal fluid (CSF) among subjects enrolled in an ongoing tuberculous meningitis study from 2014 to 2016 in Lusaka. JCV regulatory region was further characterized by duplex PCR in patients’ urine and CSF. Of 440 HIV+ patients, 14 (3%) had detectable JCV DNA in their CSF (age 18–50; CD4+ T cells counts 15–155 × 106/μl) vs 0/60 HIV− patients. The main clinical manifestations included altered mental status and impaired consciousness consistent with advanced PML. While prototype JCV was identified by duplex PCR assay in the CSF samples of all 14 PML patients, only archetype JCV was detected in their urine. All PML Zambian patients tested were seropositive for JCV compared to 46% in a control group of HIV+ and HIV− Zambian patients without PML. PML occurs among HIV-infected individuals in Zambia and is caused by CNS infection with prototype JCV, while archetype JCV strains are present in their urine. JCV seroprevalence is comparable in Zambia and the USA, and PML should be included in the differential diagnosis of immunosuppressed individuals presenting with neurological dysfunction in Zambia.
Tài liệu tham khảo
Chima SC, Agostini HT, Ryschkewitsch CF, Lucas SB, Stoner GL (1999) Progressive multifocal leukoencephalopathy and JC virus genotypes in West African patients with acquired immunodeficiency syndrome: a pathologic and DNA sequence analysis of 4 cases. Arch Pathol Lab Med 123(5):395–403
Gorelik L, Lerner M, Bixler S, Crossman M, Schlain B, Simon K, Pace A, Cheung A, Chen LL, Berman M, Zein F, Wilson E, Yednock T, Sandrock A, Goelz SE, Subramanyam M (2010) Anti-JC virus antibodies: implications for PML risk stratification. Ann Neurol 68(3):295–303
Gossai A, Waterboer T, Nelson HH, Michel A, Willhauck-Fleckenstein M, Farzan SF, Hoen AG, Christensen BC, Kelsey KT, Marsit CJ, Pawlita M, Karagas MR (2016) Seroepidemiology of human polyomaviruses in a US population. Am J Epidemiol 183(1):61–69
Jensen PN, Major EO (2001) A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region. J Neuro-Oncol 7(4):280–287
Kumwenda JJ, Mateyu G, Kampondeni S, van Dam AP, van Lieshout L, Zijlstra EE (2005) Differential diagnosis of stroke in a setting of high HIV prevalence in Blantyre, Malawi. Stroke 36(5):960–964
Lucas SB, Hounnou A, Peacock C, Beaumel A, Djomand G, N'Gbichi JM, Yeboue K, Honde M, Diomande M, Giordano C et al (1993) The mortality and pathology of HIV infection in a west African city. AIDS 7(12):1569–1579
Millogo A, Sawadogo AB, Lankoande D, Ouedraogo I (2001) Diagnostic problems of expansive intracranial process in HIV infected patients of the Bobo-Dioulasso Central Hospital (Burkina Faso). Bull Soc Pathol Exot 94(4):315–318
Modi M (2008) Progressive multifocal leucoencephalopathy--a case report. S Afr Med J 98(4):263–264
Pfister LA, Letvin NL, Koralnik IJ (2001) JC virus regulatory region tandem repeats in plasma and central nervous system isolates correlate with poor clinical outcome in patients with progressive multifocal leukoencephalopathy. J Virol 75(12):5672–5676
Ryschkewitsch CF, Jensen PN, Major EO (2013) Multiplex qPCR assay for ultra sensitive detection of JCV DNA with simultaneous identification of genotypes that discriminates non-virulent from virulent variants. J Clin Virol 57(3):243–248
Schutte CM, Ranchhod N, Kakaza M, Pillay M (2013) AIDS-related progressive multifocal leukoencephalopathy (PML): a retrospective study from Pretoria, South Africa. S Afr Med J 103(6):399–401
Shankar SK, Satishchandra P, Mahadevan A, Yasha TC, Nagaraja D, Taly AB, Prabhakar S, Nath A (2003) Low prevalence of progressive multifocal leukoencephalopathy in India and Africa: is there a biological explanation? J Neuro-Oncol 9(Suppl 1):59–67
Siddiqi OK, Ghebremichael M, Dang X, Atadzhanov M, Kaonga P, Khoury MN, Koralnik IJ (2014) Molecular diagnosis of central nervous system opportunistic infections in HIV-infected Zambian adults. Clin Infect Dis 58(12):1771–1777
Stoner GL, Agostini HT, Ryschkewitsch CF, Mazlo M, Gullotta F, Wamukota W, Lucas S (1998) Detection of JC virus in two African cases of progressive multifocal leukoencephalopathy including identification of JCV type 3 in a Gambian AIDS patient. J Med Microbiol 47(8):733–742
Waterboer T, Sehr P, Michael KM, Franceschi S, Nieland JD, Joos TO, Templin MF, Pawlita M (2005) Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem 51(10):1845–1853